The U.S. Trustee, the bankruptcy arm of the Justice Department, will appoint one or more committees to represent the interests of creditors and stockholders in working with the company to develop a plan of reorganization to get out of debt.
Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH).
All provincial drug plans now cover the cost of Soliris for the 90 or so patients in Canada with paroxysmal nocturnal hemoglobinuria (PNH), a rare disorder that destroys red blood cells, threatening organ damage, heart attacks, stroke and blood clots.